ONCOLOGY 101

A Hematology and Oncology Primer for Advanced Practice Providers

April 23 - 25 2026 (Virtual)

Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers - Spring 2026

An onboarding program that helps establish a baseline knowledge of hematology and oncology

To help APPs and other clinicians prepare for a new career in the specialty of oncology, Horizon CME in partnership with APAO has developed “Oncology 101: A Hematology and Oncology Primer for Advanced Practice Providers”. In this two-and-a-half-day program, clinicians will gain a basic understanding of cancer therapies, benign and malignant hematologic disorders, solid malignancies, supportive care strategies, oncologic emergencies, genetics and molecular testing, and more. Participation in this program will provide APPs with the foundational knowledge they need to provide support and care to cancer patients as part of the multidisciplinary oncology care team.

This program is appropriate for nurse practitioners, physician assistants, nurses, and pharmacists in hematology/oncology seeking an in-depth review of cancer treatment strategies and therapies.

Oncology 101 Logo

Registration Details

Advanced Registration

$ 175
00
  •  
DEADLINE: MAR 23

General Registration

$ 225
00
  •  
DEADLINE: APR 23

Student/Fellows*

$ 50
00
  •  
DEADLINE: APR 23
REGISTER HERE!

In Partnership With:

*Students - Fellows

Student is defined as currently enrolled in an advanced learning institution and/or studying in order to enter a particular profession.

If you would like to attend as a Student, please contact info@horizoncme.com for further information.

**Industry Employee - $400+

**Defined as anyone employed by a drug, device, or diagnostic company. The primary goal of the conference is to educate practicing clinicians on the latest advances and strategies in the care of cancer patients. Because space is limited and to ensure sufficient seats are available for clinicians, Industry Employees may register as an attendee only if you have a clinical title (NP, PharmD, MD, PA, etc). 

Conference Planning Committee

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN

Nurse Practitioner Department of Hematology and Medical Oncology Cleveland Clinic Cleveland, OH

Beth Sandy, MSN, CRNP

Nurse Practitioner Abramson Cancer Center, University of Pennsylvania Philadelphia, PA

Val R. Adams, PharmD, FCCP, FHOPA, BCOP

Associate Professor, Oncology Specialist University of Kentucky Lexington, KY

Jonathan Catrona MS, RPA-C

Advanced Practice Clinical Education Specialist Chair, OneOncology OneCouncil APP Committee New York Cancer and Blood Specialists New York, NY

Learning Objectives

  1. Outline strategies for the treatment of common solid and hematologic malignancies, including emerging and targeted therapies.
  2. Summarize the role of genetics, molecular testing, and biomarkers in guiding cancer care.
  3. Implement palliative care, pain management, and supportive care strategies for patients with cancer, including survivorship and quality-of-life considerations.
  4. Discuss strategies for the administration and management of chemotherapy and other systemic therapies.
  5. Identify and appropriately manage immune-related adverse events and therapy-specific toxicities.
  6. Recognize and treat the adverse effects associated with radiation oncology effectively.
  7. Appreciate the role of multidisciplinary care, including surgical interventions, in optimizing patient outcomes.

Intended Learners

This activity is intended for oncology nurse practitioners, physician assistants, nurses, nurse navigators, medical assistants, and other healthcare providers involved in the care of cancer patients.